View all / combine content
Topic No. 1: Staff Observations in the Review of Forms 8-K FiledTopic No. 2: CybersecurityTopic No. 3: Staff Observations in the Review of Promotional and Sales Material Submitted Pursuant to Securities Act Industry Guide 5Topic No. 4: European Sovereign Debt ExposuresTopic No. 5: Staff Observations Regarding Disclosures of Smaller Financial InstitutionsTopic No. 6: Staff Observations Regarding Disclosures of Non-Traded Real Estate Investment TrustsTopic No. 7: Confidential Treatment Applications Submitted Pursuant to Rules 406 and 24b-2Topic No. 8: Intellectual Property and Technology Risks Associated with International Business OperationsTopic No. 9: Coronavirus (COVID-19) Topic No. 9A: Coronavirus (COVID-19) — Disclosure Considerations Regarding Operations, Liquidity, and Capital ResourcesTopic No. 10: Disclosure Considerations for China-Based IssuersTopic No. 11: Special Purpose Acquisition Companies
Topic No. 1: Staff Observations in the Review of Forms 8-K FiledTopic No. 2: CybersecurityTopic No. 3: Staff Observations in the Review of Promotional and Sales Material Submitted Pursuant to Securities Act Industry Guide 5Topic No. 4: European Sovereign Debt ExposuresTopic No. 5: Staff Observations Regarding Disclosures of Smaller Financial InstitutionsTopic No. 6: Staff Observations Regarding Disclosures of Non-Traded Real Estate Investment TrustsTopic No. 7: Confidential Treatment Applications Submitted Pursuant to Rules 406 and 24b-2Topic No. 8: Intellectual Property and Technology Risks Associated with International Business OperationsTopic No. 9: Coronavirus (COVID-19) Topic No. 9A: Coronavirus (COVID-19) — Disclosure Considerations Regarding Operations, Liquidity, and Capital ResourcesTopic No. 10: Disclosure Considerations for China-Based IssuersTopic No. 11: Special Purpose Acquisition Companies